NL-OMON47072已完成不适用
The effects of FGF23 and Klotho on vascular calcification in end stage renal disease patients;<br> - FGF23 and vascular calcification
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Participating in the (pre)dialysis program
- •Informed consent.
排除标准
- •Age below 18 years.
- •Withdrawal of consent.
研究者
相似试验
已完成
不适用
Changes in FGF23 and soluble Klotho levels in incident hemodialysis patientsEnd Stage Renal DiseaseJPRN-UMIN000023536Tokai University School of Medicine50
已完成
4 期
Effect of Phosphate Binders on FGF-23 With Concurrent CalcitriolChronic Kidney Disease Stage 3NCT01748396Seoul National University Hospital30
已完成
4 期
Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)We Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients.NCT01135615Gulhane School of Medicine100
已完成
早期 1 期
Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney DiseaseChronic Kidney DiseaseNCT01308242Milton S. Hershey Medical Center40
Unknown
不适用
Klotho in Chronic Kidney Disease-associated Pruritis (CKD-aP)Chronic Kidney Disease-associated PruritusNCT03532568Cairo University60